Skip to main content

Web Content Display Web Content Display

Skip banner

Web Content Display Web Content Display

Logotyp Una Europa

Logotyp Uczelnia Badawcza Inicjatywa Doskonałości

 

Web Content Display Web Content Display

Web Content Display Web Content Display

News

Open positions in DigiWorld PRA

14.03.2021
The DigiWorld Priority Research Area announces a competitive selection process for the posts of Assistant Professors in the research and faculty staff member group in academic disciplines: socio-economic geography and spatial management and Earth and related environmental sciences in two research domains (see PRA Description tab at https://id.uj.edu.pl/digiworld): Advanced computing and Artificial Intelligence (AI) and AI in exact and natural sciences.
Read More o Open positions in DigiWorld PRA

DigiWorld call results: young researchers’ mini-grant project proposals 2021/1

17.03.2021
The DigiWorld PRA announces the results of its mini-grants for the young 2021/1 call for research projects under the strategic programme Excellence Initiative at the Jagiellonian University in the academic year 2020/2021.
Read More o DigiWorld call results: young researchers’ mini-grant project proposals 2021/1

A PCR chamber: qLIFE PRA

12.03.2021
The Chair of Physiology, JU Medical College, has operated a new chamber for contamination-free DNA sequencing (a PCR chamber).
Read More o A PCR chamber: qLIFE PRA

Safe and reliable growth of cell cultures thanks to a new CO2 incubator - the qLIFE PRA

12.03.2021
Read More o Safe and reliable growth of cell cultures thanks to a new CO2 incubator - the qLIFE PRA

Clinical development success rates and social value of pediatric Phase 1 trials in oncology

12.03.2021
A team of researchers led by bioethicist dr hab. Marcin Waligóra, professor of the Jagiellonian University, conducted an analysis in which they measured the indicators of the social value of Phase 1 clinical trials in oncology, which are not passed to the next phases.
Read More o Clinical development success rates and social value of pediatric Phase 1 trials in oncology